Tag: Ulcerative colitis

AzurRx BioPharma acquires US biotech company First Wave Bio for $229m

businessnewstoday- September 14, 2021 0

AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments ... Read More

Zydus Cadila gets FDA approval for Mesalamine Extended-Release Capsules

businessnewstoday- August 16, 2021 0

Zydus Cadila said that it has secured final approval from the US Food and Drug Administration (FDA) to market Mesalamine Extended-Release Capsules in the strength ... Read More

Microbiome company Vedanta Biosciences raises $68m in Series D

businessnewstoday- July 21, 2021 0

Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D financing round led by affiliates of Magnetar ... Read More

Merck to acquire US biotech company Pandion Therapeutics for $1.8bn

businessnewstoday- February 25, 2021 0

Merck has agreed to acquire Pandion Therapeutics, a Massachusetts-based clinical-stage biotech company, for about $1.85 billion in an all-cash deal. Pandion Therapeutics is engaged in ... Read More

ExeGi Pharma gets FDA orphan drug status for EXE-346 in pouchitis

pharmanewsdaily- November 15, 2020 0

ExeGi Pharma said that EXE-346 has been granted an orphan drug designation from the US Food and Drug Administration (FDA) for the prevention of disease ... Read More

Seres Therapeutics begins phase 1b trial of SER-301 in ulcerative colitis

pharmanewsdaily- November 8, 2020 0

Seres Therapeutics has dosed the first patient in a phase 1b clinical trial, which is assessing SER-301 for the treatment of active mild-to-moderate ulcerative colitis ... Read More

BMS’ Zeposia succeeds in True North clinical trial in ulcerative colitis

pharmanewsdaily- October 11, 2020 0

Bristol Myers Squibb (BMS) said that the phase 3 True North clinical trial evaluating Zeposia (ozanimod) in adult patients with moderate to severe ulcerative colitis ... Read More

Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle

pharmanewsdaily- January 27, 2020 0

Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma ... Read More

Janssen bags Stelara FDA approval for ulcerative colitis treatment

pharmanewsdaily- October 22, 2019 0

Stelara FDA approval for ulcerative colitis treatment : The Janssen Pharmaceutical Companies of Johnson & Johnson has bagged approval from the US Food and Drug ... Read More

Teva launches generic version of Delzicol delayed-release capsules in US

pharmanewsdaily- May 19, 2019 0

Israeli pharma company Teva Pharmaceuticals has launched a generic version of Delzicol (mesalamine) 400mg delayed-release capsules in the US. Mesalamine Delayed-Release capsules are an aminosalicylate, ... Read More